CN1065265A - 旋光氨基酮衍生物及其制备方法 - Google Patents

旋光氨基酮衍生物及其制备方法 Download PDF

Info

Publication number
CN1065265A
CN1065265A CN92101679A CN92101679A CN1065265A CN 1065265 A CN1065265 A CN 1065265A CN 92101679 A CN92101679 A CN 92101679A CN 92101679 A CN92101679 A CN 92101679A CN 1065265 A CN1065265 A CN 1065265A
Authority
CN
China
Prior art keywords
butyryl
phenyl
solution
isoxazole
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN92101679A
Other languages
English (en)
Chinese (zh)
Inventor
棚田英树
逆井一也
梶谷征太郎
大户范雄
堀込和利
水智彰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Publication of CN1065265A publication Critical patent/CN1065265A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Gyroscopes (AREA)
  • Electroluminescent Light Sources (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
CN92101679A 1991-02-26 1992-02-26 旋光氨基酮衍生物及其制备方法 Pending CN1065265A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30739/91 1991-02-26
JP3073991 1991-02-26

Publications (1)

Publication Number Publication Date
CN1065265A true CN1065265A (zh) 1992-10-14

Family

ID=12312042

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92101679A Pending CN1065265A (zh) 1991-02-26 1992-02-26 旋光氨基酮衍生物及其制备方法

Country Status (12)

Country Link
EP (1) EP0501713B1 (enrdf_load_stackoverflow)
JP (1) JP3164631B2 (enrdf_load_stackoverflow)
KR (1) KR950006156B1 (enrdf_load_stackoverflow)
CN (1) CN1065265A (enrdf_load_stackoverflow)
AT (1) ATE152446T1 (enrdf_load_stackoverflow)
CA (1) CA2061785A1 (enrdf_load_stackoverflow)
DE (1) DE69219387T2 (enrdf_load_stackoverflow)
DK (1) DK0501713T3 (enrdf_load_stackoverflow)
ES (1) ES2101806T3 (enrdf_load_stackoverflow)
FI (1) FI920857A7 (enrdf_load_stackoverflow)
NO (1) NO300840B1 (enrdf_load_stackoverflow)
TW (1) TW263509B (enrdf_load_stackoverflow)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940003292B1 (ko) * 1986-10-09 1994-04-20 닛뽕 가야꾸 가부시기가이샤 광학적 활성 2-메틸-1-(4-트리플루오로메틸페닐)-3-피롤리디노-1-프로파논 및 그 제조방법
DE69017794T2 (de) * 1989-08-04 1995-08-03 Mitsui Toatsu Chemicals Aminoketonderivate und ihre Verwendung.

Also Published As

Publication number Publication date
JP3164631B2 (ja) 2001-05-08
KR950006156B1 (ko) 1995-06-09
FI920857A0 (fi) 1992-02-26
TW263509B (enrdf_load_stackoverflow) 1995-11-21
ES2101806T3 (es) 1997-07-16
EP0501713B1 (en) 1997-05-02
KR920016451A (ko) 1992-09-24
JPH0551380A (ja) 1993-03-02
NO300840B1 (no) 1997-08-04
DE69219387T2 (de) 1997-08-21
FI920857L (fi) 1992-08-27
DK0501713T3 (da) 1997-09-08
AU1123592A (en) 1992-09-03
NO920749D0 (no) 1992-02-25
EP0501713A1 (en) 1992-09-02
DE69219387D1 (de) 1997-06-05
AU633768B2 (en) 1993-02-04
ATE152446T1 (de) 1997-05-15
FI920857A7 (fi) 1992-08-27
NO920749L (no) 1992-08-27
CA2061785A1 (en) 1992-08-27

Similar Documents

Publication Publication Date Title
CN1119319C (zh) (－)6－氯－4－环丙基乙炔基－4－三氟甲基－1,4－二氢－2h－3,1－苯并噁嗪－2－酮的不对称合成
CN1527814A (zh) 氧化氮合酶抑制剂磷酸盐
CN1303367A (zh) 氧化氮合酶抑制剂
CN101062897A (zh) 一种制备2，3－二氢－1h－茚－1－胺及其衍生物的改进方法
CN1127114A (zh) 取代的4-苯基-6-氨基烟酸衍生物作为药物的应用
DE11840625T1 (de) Verfahren zur Herstellung von Ramipiril
CN101039917A (zh) 制备替米沙坦的方法
CN1882535A (zh) 2－氧代－1－吡咯烷衍生物的制备方法
CN1578762A (zh) 外消旋坦洛新游离碱和制备它的方法
CN86107544A (zh) 黄酮衍生物的制备方法
JP2004504319A (ja) ４−フェニルピペリジン誘導体の新規製造方法
CN1349404A (zh) 多环2－氨基噻唑体系在预防或治疗肥胖的药物制备中的用途
CN1192025C (zh) 取代4－苯基－4－氰基环己烷羧酸的制备方法
CN1065265A (zh) 旋光氨基酮衍生物及其制备方法
CN1037704A (zh) 对映体的戊二酰胺利尿剂
CN1063487A (zh) 苯氧基烷基羧酸衍生物及其制备方法
JP2002544252A (ja) Ｓ−（−）−クロロコハク酸またはその誘導体からｒ−（−）−カルニチンを調製するための方法
CN1882526A (zh) 制备伏格列波糖的方法
CN100342851C (zh) 包含西布曲明甲磺酸盐半水合物晶体的药物组合物
CN1100054C (zh) 由(2s)－4－吡啶甲基－2－哌嗪－叔丁基甲酰胺制备hiv蛋白酶抑制剂的方法
CN1091743A (zh) 吡咯衍生物，其制备方法及其在治疗上的应用
CN1279018C (zh) 一种制备右旋α－[2－（萘氧基）乙基]苯甲胺衍生物的方法
CN1147512A (zh) 取代的4h-吡喃化合物
CN1217923C (zh) 通过α－氯代环氧酯制备酸的方法
CN1742002A (zh) 新的哌嗪衍生物和它们作为合成中间体的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Applicant after: Mitsui Chemical Industry Co., Ltd.

Applicant before: Mitsui Toatsu Chem. Inc.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: MITSUI TOATSU CHEMICALS, LTD. TO: MITSUI CHEMICALS, INC.

AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned